SENNI, MICHELE

SENNI, MICHELE  

DIPARTIMENTO DI MEDICINA E CHIRURGIA (SCHOOL OF MEDICINE AND SURGERY)  

Mostra records
Risultati 1 - 20 di 503 (tempo di esecuzione: 0.029 secondi).
Titolo Tipologia Data di pubblicazione Autori File
A rare case of cytomegalovirus myocarditis complicating rejection after heart transplantation: Case report and review of literature 01 - Articolo su rivista 2025 Senni M. +
Anaemia in patients with heart failure and mildly reduced or preserved ejection fraction: A prespecified analysis of the FINEARTS-HF trial 01 - Articolo su rivista 2025 Senni M. +
Angiotensin Receptor Neprilysin Inhibition and Cardiovascular Outcomes Across the Kidney Function Spectrum: The PARAGON-HF Trial 01 - Articolo su rivista 2025 Gori M.Senni M. +
ANMCO position paper: Diagnosis and treatment of heart failure with preserved ejection fraction 01 - Articolo su rivista 2025 Senni M. +
ANMCO position paper: diagnosis and treatment of heart failure with preserved systolic function 01 - Articolo su rivista 2025 Senni M. +
Assessing palliative care needs in worsening heart failure patients: Insights from OPPORTUNITIES registry 01 - Articolo su rivista 2025 Senni M. +
Baseline characteristics of contemporary trial participants with heart failure and reduced ejection fraction: The VICTOR trial 01 - Articolo su rivista 2025 Senni M. +
Blinded Withdrawal of Finerenone After Long-Term Treatment in the FINEARTS-HF Trial 01 - Articolo su rivista 2025 Senni M. +
Changes in natriuretic peptide levels following patiromer-enabled optimization of medical therapy in heart failure: A post hoc analysis of the DIAMOND study 01 - Articolo su rivista 2025 Senni M. +
Economic Evaluation of Patiromer in Patients with Concomitant Heart Failure and Chronic Kidney Disease in Italy 01 - Articolo su rivista 2025 Senni M. +
Effect of Finerenone on the KCCQ in Patients With HFmrEF/HFpEF: A Prespecified Analysis of FINEARTS-HF 01 - Articolo su rivista 2025 Senni M. +
Effects of finerenone on natriuretic peptide levels in heart failure with mildly reduced or preserved ejection fraction: The FINEARTS-HF trial 01 - Articolo su rivista 2025 Senni M. +
Effects of Finerenone on Readmissions for Heart Failure: Insights From the FINEARTS-HF Trial 01 - Articolo su rivista 2025 SENNI M. +
Effects of the Nonsteroidal MRA Finerenone With and Without Concomitant SGLT2 Inhibitor Use in Heart Failure 01 - Articolo su rivista 2025 Senni M. +
Efficacy and Safety of Finerenone Across the Ejection Fraction Spectrum in Heart Failure With Mildly Reduced or Preserved Ejection Fraction: A Prespecified Analysis of the FINEARTS-HF Trial 01 - Articolo su rivista 2025 Senni M. +
Efficacy and Safety of Finerenone in Heart Failure With Preserved Ejection Fraction: A FINE-HEART Analysis 01 - Articolo su rivista 2025 Senni M. +
Efficacy and Safety of Finerenone in Type 2 Diabetes: A Pooled Analysis of Trials of Heart Failure and Chronic Kidney Disease 01 - Articolo su rivista 2025 Senni M. +
Estimated Long-Term Benefits of Finerenone in Heart Failure: A Prespecified Secondary Analysis of the FINEARTS-HF Randomized Clinical Trial 01 - Articolo su rivista 2025 Senni M. +
Exercise Right Ventricular-Pulmonary Arterial Coupling and Functional Outcome in Patients Undergoing Surgery for Secondary Ischemic Mitral Regurgitation 01 - Articolo su rivista 2025 Merlo M.Senni M.Marchetto G.Iacovoni A. +
Exploring the impact of metabolic comorbidities on epicardial adipose tissue in heart failure with preserved ejection fraction 01 - Articolo su rivista 2025 Senni M. +